Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 2.07 | 2.22 | 2.32 | 1.68 |
Depreciation/ Depletion | 0.58 | 0.52 | 0.53 | 0.56 |
Non- Cash Items | -0.17 | -0.04 | 0.10 | 0.07 |
Changesin Working Capital | -1.72 | -2.47 | -2.00 | 5.29 |
Cashfrom Operating Activities | 0.76 | 0.22 | 0.95 | 7.59 |
Capital Expenditures | -1.43 | -1.07 | -0.84 | -0.13 |
Other Investing Cash Flow Items Total | 0.12 | 1.61 | -4.63 | -5.45 |
Cashfrom Investing Activities | -1.31 | 0.54 | -5.47 | -5.58 |
Financing Cash Flow Items | 0.00 | -0.08 | -0.11 | 0.79 |
Total Cash Dividends Paid | -0.72 | -0.66 | -0.32 | - |
Issuance( Retirement)of Stock Net | 0.00 | 1.32 | 1.38 | 1.74 |
Cashfrom Financing Activities | -0.72 | 0.58 | 0.93 | 1.30 |
Net Changein Cash | -1.27 | 1.34 | -3.59 | 3.31 |
Cash Taxes Paid | 0.50 | 0.70 | 0.88 | 0.46 |
Issuance( Retirement)of Debt Net | - | - | -0.02 | -1.23 |
Sandu Pharmaceuticals Dividend Sandu Pharmaceuticals Bonus Sandu Pharmaceuticals News Sandu Pharmaceuticals AGM Sandu Pharmaceuticals Rights Sandu Pharmaceuticals Splits Sandu Pharmaceuticals Board Meetings Sandu Pharmaceuticals Key Metrics Sandu Pharmaceuticals Shareholdings Sandu Pharmaceuticals Profit Loss Sandu Pharmaceuticals Balance Sheet Sandu Pharmaceuticals Q1 Results Sandu Pharmaceuticals Q2 Results Sandu Pharmaceuticals Q3 Results Sandu Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks